Summit Healthcare Acquisition Corp.
SMIH
NASDAQ Capital Market13.00
USD
-0.05
- -
CIK
0001839185
ISIN
KYG8566R1020
CUSIP
G8566R102
Return %
Stock
S&P500
1Y
33.33
18.21
3Y
37.13
64.38
5Y
37.13
72.43
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Bo Tan
- Sector
- Financial Services
- Industry
- Shell Companies
- Address
- 1 Lyndhurst Tower Central Hong Kong
- IPO Date
- Jul 30, 2021
- CIK
- 0001839185
- Similar Companies
- Business
- Summit Healthcare Acquisition Corp. (SMIH) is a blank check company focused on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses, primarily targeting the healthcare industry. The company has not yet commenced operations and its activities are limited to organizational matters and activities related to the initial public offering and search for a suitable target; it offers no current products or services beyond its standard SPAC structure for facilitating such transactions. Founded in 2024 and headquartered in New York, New York, it operates principally in the United States with a focus on healthcare targets including providers, services, therapeutics, diagnostics, and technology-enabled solutions. No recent partnerships, funding rounds, acquisitions, new product launches, strategic shifts, expansions, name changes, or significant operational changes have been publicly reported for Summit Healthcare Acquisition Corp. within the last 1-2 years.
EQUITY ALERT: ROSEN, LEADING TRIAL ATTORNEYS, Encourages YS Biopharma Co., Ltd. f/k/a Summit Healthcare Acquisition Corp. Investors to Inquire About Securities Class Action Investigation – YS, SMIH